CYP2D6 Gene Polymorphisms and Variable Metabolic Activity in Schizophrenia Patients of Han and Tibetan Populations

BACKGROUND: It has been suggested that the pharmacogenomic response to antipsychotics in schizophrenia patients partially contributed by drug metabolism enzyme polymorphism, including P450 2D6 (CYP2D6). However, CYP2D6 gene polymorphism across populations is largely unknown. MATERIALS AND METHODS: H...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yong-Hang, Huang, Wei, Xiao, Man-Yu, Huang, Shi-Qing, Chen, Hui, Li, Zai-Fang, Li, Xue-Song, Cheng, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986482/
https://www.ncbi.nlm.nih.gov/pubmed/35401003
http://dx.doi.org/10.2147/NDT.S355985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986482/
https://www.ncbi.nlm.nih.gov/pubmed/35401003
http://dx.doi.org/10.2147/NDT.S355985

Ejemplares similares